Predicting response of ovarian cancer to paclitaxel treatment based on trend analysis of serum CA125

被引：0
|
作者：
Nekulova, M
Pecen, L
Kalabova, R
Simickova, M
Topolcan, O
Pikner, R
Vondracek, V
Valik, D
机构：
[1] Masaryk Mem Canc Inst, Dept Lab Med, Brno 65665, Czech Republic
[2] Masaryk Mem Canc Inst, Dept Gynecol, Brno 65665, Czech Republic
[3] Charles Univ, Dept Nucl Med, Plzen 30599, Czech Republic
来源：
CLINICAL CHEMISTRY | 2002年 / 48卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
下载
收藏
页码：1364 / 1367
页数：4
相关论文
共 50 条
  • [41] Prechemotherapy serum CA125 level, CA125 kinetics and its half-life as prognostic factors in advanced ovarian cancer.
    Colakovic, S
    Lukic, V
    Mitrovic, L
    Jelic, S
    Susnjar, S
    Marinkovic, J
    ANNALS OF ONCOLOGY, 2000, 11 : 82 - 83
  • [42] Personalizing CA125 Levels for Ovarian Cancer Screening
    Dorigo, Oliver
    Berek, Jonathan S.
    CANCER PREVENTION RESEARCH, 2011, 4 (09) : 1356 - 1359
  • [43] High grade, advanced, serous ovarian cancer with low serum CA125 levels
    Asali, Aula
    Haj-Yehia, Nasreen
    Zehavi, Tania
    Perry, Talila
    Beiner, Mario
    Fishman, Ami
    Kadan, Yfat
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 41 (07) : 1107 - 1111
  • [44] Postprandial increase in serum CA125 as a surrogate biomarker for early diagnosis of ovarian cancer
    Zhuowei Gu
    Yifeng He
    Yue Zhang
    Mo Chen
    Keqi Song
    Yuting Huang
    Qing Li
    Wen Di
    Journal of Translational Medicine, 16
  • [45] Using Serum CA125 to Assess the Activity of Potential Cytostatic Agents in Ovarian Cancer
    Hall, Marcia R.
    Petruckevitch, Ann
    Pascoe, Joanna
    Persic, Mojca
    Tahir, Saad
    Morgan, Jamie S.
    Gourley, Charlie
    Stuart, Nick
    Crawford, S. Michael
    Kornbrot, Diana E.
    Qian, Wendi
    Rustin, Gordon J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (04) : 676 - 681
  • [46] Postprandial increase in serum CA125 as a surrogate biomarker for early diagnosis of ovarian cancer
    Gu, Zhuowei
    He, Yifeng
    Zhang, Yue
    Chen, Mo
    Song, Keqi
    Huang, Yuting
    Li, Qing
    Di, Wen
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [47] CA125 AS A SERUM MARKER FOR POOR PROGNOSIS IN OVARIAN MALIGNANCIES
    ALVAREZ, RD
    TO, A
    BOOTS, LR
    SHINGLETON, HM
    HATCH, KD
    HUBBARD, J
    SOONG, SJ
    POTTER, ME
    GYNECOLOGIC ONCOLOGY, 1987, 26 (03) : 284 - 289
  • [48] Cancergazing? CA125 and post-treatment surveillance in advanced ovarian cancer
    Jordens, Christopher F. C.
    Morrell, Bronwen
    Harnett, Paul
    Hobbs, Kim
    Mason, Catherine
    Kerridge, Ian H.
    SOCIAL SCIENCE & MEDICINE, 2010, 71 (09) : 1548 - 1556
  • [49] CA125 GLYCOFORM ASSAY IMPROVES THE PERFORMANCE OF CONVENTIONAL CA125 IN THE DIAGNOSTICS OF EPITHELIAL OVARIAN CANCER
    Salminen, L.
    Gidwani, K.
    Rolfsen, A. L.
    Nadeem, N.
    Bolstad, N.
    Dorum, A.
    Grenman, S.
    Hietanen, S.
    Perheentupa, A.
    Poutanen, M.
    Carpen, O.
    Lamminmaki, U.
    Pettersson, K.
    Hynninen, J.
    Huhtinen, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 825 - 825
  • [50] Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening
    Menon, U
    Talaat, A
    Rosenthal, AN
    Macdonald, ND
    Jeyerajah, AR
    Skates, SJ
    Sibley, K
    Oram, DH
    Jacobs, IJ
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2000, 107 (02): : 165 - 169
12345